On March 4, 2019 Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, reported its participation in the following upcoming investor conferences (Press release, Moderna Therapeutics, MAR 4, 2019, View Source [SID1234533941]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 39th Annual Health Care Conference in Boston on Monday, March 11, 2019 at 2:50 p.m. ET.
Barclays Global Healthcare Conference 2019 in Miami on Thursday, March 14, 2019 at 8:30 a.m. ET.
Oppenheimer 29th Annual Healthcare Conference in New York on Tuesday, March 19, 2019 at 8:35 a.m. ET.
A live webcast of each presentation will be available under "Events & Presentations" in the Investors section of the Moderna website at View Source A replay of each webcast will be archived on Moderna’s website for 30 days following the presentations.